Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SULT1A1 Activity Variability in Healthy Adults
NCT03182595Phase 1Completed
- Sponsor
- Hospital da Luz
- Start
- Mar 2017
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Hospital da Luz. Primary endpoint: Coefficient of variation of paracetamol sulfonation index (PSI) at 9 months. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT03182595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03182595.